"All Smoking Products are Harmful" Responds HK Health Dept. to 2FIRSTS

Regulations by 2FIRSTS
Jan.02.2024
"All Smoking Products are Harmful" Responds HK Health Dept. to 2FIRSTS
Hong Kong's e-cigarette market faces high prices and rampant counterfeit products, as a ban imposes restrictions.

On April 30, 2022, what some insiders called the "strictest ever" e-cigarette ban came into effect in Hong Kong, China. A year and a half later, in December 2023, 2FIRSTS conducted an undercover investigation into the e-cigarette market in Hong Kong, revealing a rampant problem of exorbitant prices and counterfeit products. Local e-cigarette consumers were forced to resort to unofficial channels, paying higher prices for inferior quality products.

 

In light of these findings, 2FIRSTS reached out to the Hong Kong Department of Health for further information. The department responded, reiterating the government's commitment to protecting public health and highlighting the implementation of the Revised Smoking (Public Health) Bill 2019 which came into effect on April 30, 2022. The bill prohibits the import, manufacture, sale, distribution, and promotion of alternative smoking products, including e-cigarettes, heated tobacco products, and herbal cigarettes in Hong Kong.

 

The authorities also mentioned the release of a public consultation document titled "A Dynamic, Healthy, and Smoke-free Hong Kong," through which the public and media can provide their feedback.

 

The full text of the response is as follows:

 

In June 2023, the Hong Kong government eased restrictions on transportation management, allowing for the transit of e-cigarette products within Hong Kong. Will the government's attitude towards regulating e-cigarettes continue to shift? Can the underground market for e-cigarettes in Hong Kong be improved in the short term? Will the situation of e-cigarette users in Hong Kong be guaranteed? 2FIRSTS will continue to monitor the regulatory developments in the Hong Kong e-cigarette market and maintain active communication with local regulatory authorities.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
Multi-State Coalition Urges F1 to End Nicotine Sponsorships, Citing Zyn and Velo
Multi-State Coalition Urges F1 to End Nicotine Sponsorships, Citing Zyn and Velo
Hawaii Attorney General Anne Lopez is co-leading a coalition of 19 states and jurisdictions urging the Fédération Internationale de l’Automobile (FIA) and Formula 1 to end sponsorships involving tobacco and nicotine products, including nicotine pouch brands such as Zyn and Velo.
News
Jun.09
Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy Fines PMI €7 Million Over Misleading ‘Smoke-Free Future’ Marketing Claims
Italy’s Competition and Market Authority (AGCM) has fined Philip Morris Italia €7 million, finding that the company’s use of “smoke-free future” and related claims in promoting products such as IQOS, VEEV and ZYN could mislead consumers.
Jun.16
Illegal Vape Retailers in UK Could Face 12-Month Shutdowns
Illegal Vape Retailers in UK Could Face 12-Month Shutdowns
The UK government plans to expand police and trading standards powers by extending closure orders for shops selling illegal vapes and cigarettes from a maximum of six months to 12 months, in a crackdown on organised crime on high streets.
Jun.12
Australian State Targets Illegal Tobacco Retailers With Tougher Closure Powers
Australian State Targets Illegal Tobacco Retailers With Tougher Closure Powers
According to Reuters, Australia’s state of Victoria introduced legislation to give police and the state tobacco licensing regulator stronger powers to shut businesses selling illegal tobacco, with non-compliant operators facing fines of more than A$2.4 million and up to 20 years in prison.
Jun.05
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
CBP and FDA Seize 18 Million Illegal Vapes Worth $175 Million in Maritime Cargo Operation
U.S. Customs and Border Protection (CBP) announced that more than 18 million illegal e-cigarettes valued at over $175 million were seized during “Operation Red Mist,” a joint enforcement initiative involving the U.S. Coast Guard and the FDA. The operation primarily targeted maritime vape shipments originating from China and focused on combating illicit importation, transportation, and distribution activities.
Regulations
May.14